Courage Therapeutics Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 7

Courage Therapeutics General Information

Description

Developer of obesity treatment drugs designed to treat anorexia nervosa and obesity. The company uses patents relating to the composition of matter and activity to sensitize patients to anorexigenic medicines and help to treat increased feeding behavior in mouse models of feeding, enabling physicians to get access to drugs in areas of unmet medical need.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 64 Homer Street
  • Newton, MA 02459
  • United States
+1 (617)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 64 Homer Street
  • Newton, MA 02459
  • United States
+1 (617)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Courage Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Secondary Transaction - Private Completed Pre-Clinical Trials
5. Seed Round 30-Apr-2025 Completed Pre-Clinical Trials
4. Grant 23-Aug-2022 Completed Pre-Clinical Trials
3. Seed Round Completed Pre-Clinical Trials
2. Grant 01-May-2021 $251K Completed Pre-Clinical Trials
1. Grant 11-Sep-2020 $245K Completed Pre-Clinical Trials
To view Courage Therapeutics’s complete valuation and funding history, request access »

Courage Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed-1
Seed
To view Courage Therapeutics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Courage Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of obesity treatment drugs designed to treat anorexia nervosa and obesity. The company uses patents relating t
Drug Discovery
Newton, MA
4 As of 2026

Boston, MA
 

Northbrook, IL
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Courage Therapeutics Competitors (7)

One of Courage Therapeutics’s 7 competitors is Syntis Bio, a Venture Capital-Backed company based in Boston, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Syntis Bio Venture Capital-Backed Boston, MA
Endevica Bio Venture Capital-Backed Northbrook, IL
Sarepta Therapeutics Formerly VC-backed Cambridge, MA
Capricor Therapeutics Formerly VC-backed San Diego, CA
Kailera Therapeutics Formerly VC-backed Waltham, MA
You’re viewing 5 of 7 competitors. Get the full list »

Courage Therapeutics Patents

Courage Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026170042-A1 Mc4r agonist peptides and methods of use thereof Pending 06-Feb-2025
EP-4761749-A1 Anorexia-sensitizing agents Pending 18-Aug-2023
WO-2025042770-A1 Anorexia-sensitizing agents Inactive 18-Aug-2023
EP-4392072-A1 Mc4r agonist peptides Pending 24-Aug-2021
US-20240391954-A1 Mc4r agonist peptides Pending 24-Aug-2021 C07K7/06
To view Courage Therapeutics’s complete patent history, request access »

Courage Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Courage Therapeutics Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Arsenal Bridge Ventures Venture Capital Minority
Huffines Enterprises Science & Technology Investments Venture Capital Minority
Michigan Biomedical Venture Fund Venture Capital Minority
What If Ventures Venture Capital Minority
NASA SBIR/STTR Government
You’re viewing 5 of 7 investors. Get the full list »

Courage Therapeutics FAQs

  • When was Courage Therapeutics founded?

    Courage Therapeutics was founded in 2019.

  • Where is Courage Therapeutics headquartered?

    Courage Therapeutics is headquartered in Newton, MA.

  • What is the size of Courage Therapeutics?

    Courage Therapeutics has 4 total employees.

  • What industry is Courage Therapeutics in?

    Courage Therapeutics’s primary industry is Drug Discovery.

  • Is Courage Therapeutics a private or public company?

    Courage Therapeutics is a Private company.

  • What is Courage Therapeutics’s current revenue?

    The current revenue for Courage Therapeutics is .

  • How much funding has Courage Therapeutics raised over time?

    Courage Therapeutics has raised $8.8M.

  • Who are Courage Therapeutics’s investors?

    Arsenal Bridge Ventures, Huffines Enterprises Science & Technology Investments, Michigan Biomedical Venture Fund, What If Ventures, and NASA SBIR/STTR are 5 of 7 investors who have invested in Courage Therapeutics.

  • Who are Courage Therapeutics’s competitors?

    Syntis Bio, Endevica Bio, Sarepta Therapeutics, Capricor Therapeutics, and Kailera Therapeutics are some of the 7 competitors of Courage Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process